Health Care & Life Sciences » Pharmaceuticals | Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd.
Stock Exchange Bombay Stock Exchange Prices
EPS
 INR23.8
Market Cap
 INR188.83 B
Shares Outstanding
 282.17 M
Public Float
 150.05 M

Profile

Address
Glenmark House, HDO Corporate Bldg
Mumbai Maharashtra 400099
India
Employees -
Website http://www.glenmarkpharma.com
Updated 09/14/2018
Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.

Financials

View All
Created with Highcharts 5.0.14Glenmark Pharmaceuticals Ltd.Net Income. Fiscal year is April-March. All values INR Millions.5 4235 4234 7534 7537 0217 0219 1609 1607 7437 7432014201520162017201802.5k5k7.5k10k
Created with Highcharts 5.0.14Glenmark Pharmaceuticals Ltd.Sales/Revenue. Fiscal year is April-March. All values INR Millions.59 23659 23665 21665 21675 61775 61790 79490 79491 03191 03120142015201620172018025k50k75k100k

Glenn Mario Saldanha
Chairman, Chief Executive Officer & MD
V. S. Mani
President, CFO & Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.